Iovance Biotherapeutics, Inc. (IOVA)

Last Year

08-May-23 -- 07-May-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

18

0

6

+1

0

+2

0

+3

Two Year Chart

08-May-22 -- 07-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
20-Feb-24 7:52 PM View:	20-Feb-24 Private Purchase $2.29M	McPeak Merrill A/ Director		Iovance Biotherapeutics, Inc. - IOVA	84% 308.78K to 568.78K	0	0	--	--	Show Txns Hide Txns

20-Feb-24 4:11 PM View:	20-Feb-24 Private Purchase $45.75M	Rothbaum Wayne P. Director		Iovance Biotherapeutics, Inc. - IOVA	55% 18.07M to 28.07M	0	0	--	--	Show Txns Hide Txns

20-Feb-24 4:21 PM View:	20-Feb-24 Private Purchase $292.80K	Dukes Iain D. Director		Iovance Biotherapeutics, Inc. - IOVA	145% 22.0K to 54.0K	0	0	--	--	Show Txns Hide Txns

17-Apr-24 7:07 PM View:	15-Apr-24 Payment of Exercise ($16.97K)	Graf Finckenstein Friedrich Chief Medical Officer		Iovance Biotherapeutics, Inc. - IOVA	44% 29.54K to 42.56K	0	0	--	--	Show Txns Hide Txns

17-Apr-24 7:07 PM View:	15-Apr-24 Payment of Exercise ($16.97K)	Bilinsky Igor Chief Operating Officer		Iovance Biotherapeutics, Inc. - IOVA	47% 25.8K to 38.03K	0	0	--	--	Show Txns Hide Txns

17-Apr-24 7:08 PM View:	15-Apr-24 Payment of Exercise ($105.24K)	Vogt Frederick G Interim CEO & General Counsel		Iovance Biotherapeutics, Inc. - IOVA	132% 60.87K to 141.33K	0	0	--	--	Show Txns Hide Txns